Relmada Therapeutics, Inc. (RLMD): 10-Q filed Aug 6, 2026

Form type

10-Q

Filing date

Aug 6, 2026

Accession number

0001213900-26-086151

Filer

Relmada Therapeutics, Inc. (CIK 1553643)